Results 91 to 100 of about 10,221 (208)

Mean platelet volume in patients with prolactinoma

open access: yesArchives of Endocrinology and Metabolism, 2016
Objective Prolactin is a multifunctional pituitary hormone. The effect of prolactin on platelet activation is not well understood. Prolactinomas are the most common type of pituitary adenomas, and they are medically responsive to dopamine agonists. Mean
Abbas Ali Tam   +4 more
doaj   +1 more source

A study on the correlations of PRL levels with anxiety, depression, sleep, and self-efficacy in patients with prolactinoma

open access: yesFrontiers in Endocrinology
PurposeThe purpose of this study was to explore the factors influencing PRL levels in patients with prolactinoma and to investigate the correlations between anxiety, depression, sleep, self-efficacy, and PRL levels.MethodsThis retrospective study ...
Xiaoju Miao   +14 more
doaj   +1 more source

The Molecular Pathogenesis of Pituitary Adenomas: An Update [PDF]

open access: yes, 2013
Pituitary tumors represent the most common intracranial neoplasms accompanying serious morbidity through mass effects and inappropriate secretion of pituitary hormones. Understanding the etiology of pituitary tumorigenesis will facilitate the development
Jiang, Xiaobing, Zhang, Xun
core   +2 more sources

Brief Report: AIP Mutation in Pituitary Adenomas in the 18th Century and Today [PDF]

open access: yes, 2013
From New England Journal of Medicine, Volume 364, issue 1, p.43-50. Copyright © (2011) Massachusetts Medical Society. Reprinted with permission.Gigantism results when a growth hormone–secreting pituitary adenoma is present before epiphyseal fusion.
Abel, RL   +17 more
core   +1 more source

A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism [PDF]

open access: yes, 2016
Clinically nonfunctioning pituitary adenomas (NFPA) are the most common pituitary tumors after prolactinomas. The absence of clinical symptoms of hormonal hypersecretion can contribute to the late diagnosis of the disease.
Araújo, Luiz Antônio de   +9 more
core   +3 more sources

Chemometric Expertise Of Clinical Monitoring Data Of Prolactinoma Patients

open access: yesOpen Chemistry, 2019
The present investigation indicates hidden relationships between the several clinical parameters usually monitored on prolactinoma patients using non-hierarchical cluster analysis. The major goal of the chemometric data mining is to offer a possible mode
Nedyalkova Miroslava   +3 more
doaj   +1 more source

Pituitary surgery for small prolactinomas as an alternative to treatment with dopamine agonists [PDF]

open access: yes, 2018
Despite the fact that consensus guidelines recommend long-term dopamine agonist (DA) therapy as a first-line approach to the treatment of small prolactinoma, some patients continue to prefer a primary surgical approach.
Andres, Robert   +4 more
core  

Prolactinoma: A Massive Effect on Bone Mineral Density in a Young Patient

open access: yesCase Reports in Endocrinology, 2016
This case highlights a prolactinoma in a young male, and its impact on bone health. Osteoporosis has been noted to be an issue in postmenopausal women with prolactinomas.
Scott Sperling, Harikrashna Bhatt
doaj   +1 more source

Hiperprolactinemia em pacientes femininas: estudo de seis casos. [PDF]

open access: yes, 1999
Trabalho de Conclusão de Curso - Universidade Federal de Santa Catarina, Centro de Ciências da Saúde, Departamento de Tocoginecologia, Curso de Medicina, Florianópolis ...
Martins, Angelo Francisco
core  

Transcriptomic analysis of the anti-tumor effects of leflunomide in prolactinoma

open access: yesScientific Reports
Leflunomide’s anti-tumor effects have been investigated in various types of tumors; however, its impact on pituitary adenoma, particularly prolactinoma, is unclear.
Xiangdong Pei   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy